Concepedia

Cristina Fernandez‐Ibarra

CF

Statistics

Publications

4

Citations

377

H-Index

4

Active since

2011

Affiliations

Novartis (Switzerland)(Current)

Cristina Fernandez‐Ibarra is an author at Novartis (Switzerland) specializing in pharmacology, cancer pharmacology, and oncology.

Publications per year

2011–2015

4

Publications

4

First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors

Cristiana Sessa, Geoffrey I. Shapiro, Kapil N. Bhalla et al. · Clinical Cancer Research · 2013 · 162 citations

, , +16

89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research · 2014 · 118 citations

, , +16

Phase 1/1<scp>B</scp> trial of the heat shock protein 90 inhibitor <scp>NVP</scp>‐<scp>AUY</scp>922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Ruth Seggewiß-Bernhardt, Ralf C. Bargou, Yeow Tee Goh et al. · Cancer · 2015 · 72 citations · Full text

, , +14

Use of biomarkers and imaging to evaluate the treatment effect of AUY922, an HSP90 inhibitor, in patients with HER2+ or ER+ metastatic breast cancer.

C.P. Schröder, J. V. Pedersen, Sue Chua et al. · Journal of Clinical Oncology · 2011 · 25 citations

, , +17

1–4 of 4